Ikigai Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-12-2024
- Paid Up Capital ₹ 0.10 M
as on 17-12-2024
- Company Age 3 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
About Ikigai Lifesciences
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vijay Agge and Mallareddy Bokka serve as directors at the Company.
- CIN/LLPIN
U24290TG2021PTC155914
- Company No.
155914
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Oct 2021
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ikigai Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Agge  | Additional Director | 08-Jul-2023 | Current |
| Mallareddy Bokka | Additional Director | 13-Oct-2022 | Current |
Financial Performance of Ikigai Lifesciences.
Enhance accessibility to Ikigai Lifesciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ikigai Lifesciences?
Unlock access to Ikigai Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Abhayamm Food Products Private LimitedActive 1 year 2 monthsVijay Agge and Mallareddy Bokka are mutual person
- Abhayamm Milk Products Private LimitedActive 2 years 2 months
Vijay Agge and Mallareddy Bokka are mutual person
- Abhayamm Pharma Private LimitedActive 6 months 4 days
Vijay Agge and Mallareddy Bokka are mutual person
- Softdigilogix It And Allied Solutions Private LimitedActive 5 months 16 days
Vijay Agge and Mallareddy Bokka are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ikigai Lifesciences?
Ikigai Lifesciences has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ikigai Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ikigai Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
